Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 67201 - 67225 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Rosiglitazone	Approved Investigational	PON2	5445	downregulated	rosiglitazone results in decreased expression of PON2 mRNA	7q21.3	A10216
Rosiglitazone	Approved Investigational	POR	5447	upregulated	rosiglitazone results in increased expression of POR mRNA	7q11.23	A22609
Rosiglitazone	Approved Investigational	PPARD	5467	upregulated	rosiglitazone results in increased expression of PPARD mRNA	6p21.31	A24130
Rosiglitazone	Approved Investigational	PPARG	5468	upregulated	rosiglitazone results in increased expression of PPARG mRNA	3p25.2	A24096 A24097 A24131 A24111 A24127 A24132 A24125 A21655 A21590 A24133 A20877 A24098 A24135
Rosiglitazone	Approved Investigational	PPARG	5468	upregulated	rosiglitazone results in increased expression of PPARG mRNA alternative form	3p25.2	A23650
Rosiglitazone	Approved Investigational	PPARGC1A	10891	upregulated	rosiglitazone results in increased expression of PPARGC1A mRNA	4p15.2	A20416 A20536 A24130
Rosiglitazone	Approved Investigational	PPIL6	285755	upregulated	rosiglitazone results in increased expression of PPIL6 mRNA	6q21	A22609
Rosiglitazone	Approved Investigational	PPM1D	8493	upregulated	rosiglitazone results in increased expression of PPM1D mRNA	17q23.3	A20427
Rosiglitazone	Approved Investigational	PPM1G	5496	upregulated	rosiglitazone results in increased expression of PPM1G mRNA	2p23.3	A24100
Rosiglitazone	Approved Investigational	PPP1R15A	23645	upregulated	rosiglitazone results in increased expression of PPP1R15A mRNA	19q13.2	A24100 A20427
Rosiglitazone	Approved Investigational	PPP1R1A	5502	downregulated	rosiglitazone results in decreased expression of PPP1R1A mRNA	12q13.2	A22609
Rosiglitazone	Approved Investigational	PPP1R3C	5507	downregulated	rosiglitazone results in decreased expression of PPP1R3C mRNA	10q23.32	A22609
Rosiglitazone	Approved Investigational	PPP2R1A	5518	upregulated	rosiglitazone results in increased expression of PPP2R1A mRNA	19q13.41	A24100
Rosiglitazone	Approved Investigational	PRAM1	84106	upregulated	rosiglitazone results in increased expression of PRAM1 mRNA	19p13.2	A10216
Rosiglitazone	Approved Investigational	PRG4	10216	downregulated	rosiglitazone results in decreased expression of PRG4 mRNA	1q31.1	A22609
Rosiglitazone	Approved Investigational	PROC	5624	downregulated	rosiglitazone results in decreased expression of PROC mRNA	2q14.3	A22609
Rosiglitazone	Approved Investigational	PRODH	5625	upregulated	rosiglitazone results in increased expression of PRODH mRNA	22q11.21	A21657
Rosiglitazone	Approved Investigational	PROZ	8858	downregulated	rosiglitazone results in decreased expression of PROZ mRNA	13q34	A22609
Rosiglitazone	Approved Investigational	PTEN	5728	upregulated	rosiglitazone results in increased expression of PTEN mRNA	10q23.31	A24136 A24137 A24138
Rosiglitazone	Approved Investigational	PTGS2	5743	downregulated	rosiglitazone results in decreased expression of PTGS2 mRNA	1q31.1	A24139
Rosiglitazone	Approved Investigational	PTPRE	5791	upregulated	rosiglitazone results in increased expression of PTPRE mRNA	10q26.2	A22609
Rosiglitazone	Approved Investigational	QPRT	23475	downregulated	rosiglitazone results in decreased expression of QPRT mRNA	16p11.2	A10216
Rosiglitazone	Approved Investigational	RAB15	376267	downregulated	rosiglitazone results in decreased expression of RAB15 mRNA	14q23.3	A10216
Rosiglitazone	Approved Investigational	RAB1B	81876	upregulated	rosiglitazone results in increased expression of RAB1B mRNA	11q13.2	A24100
Rosiglitazone	Approved Investigational	RAB20	55647	upregulated	rosiglitazone results in increased expression of RAB20 mRNA	13q34	A10216

Displaying entries 67201 - 67225 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability